59-year-old woman with Stage 4 Breast Cancer went from 6cm tumor (and… — Fact Check: Inaccurate

What was claimed

59-year-old woman with Stage 4 Breast Cancer went from 6cm tumor (and multiple liver tumors) to completely cancer-free in 3 months using high-dose Ivermectin (72mg/day) and Fenbendazole (1500mg/day)

Our verdict

Inaccurate

Major organizations, including the American Cancer Society and oncology experts, state that ivermectin is not approved or recommended as a cancer treatment and that there is currently no evidence in human cancer patients that ivermectin decreases cancer growth. They also warn that large doses can be very dangerous, causing serious neurological effects, seizures, coma, or death. Available evidence for ivermectin’s anticancer activity comes from laboratory and animal studies, not from robust human clinical trials. The American Cancer Society and oncology experts clearly state that ivermectin has no proven benefit against cancer in people and is not approved or recommended as a cancer treatment.

1 of 3 AI systems agree9 sources citedChecked Jun 29, 2026

Check your own claim

Paste any statement, headline, or AI answer — 3 independent AIs verify it in seconds, with sources.

Key findings

There are clinical trials showing that ivermectin combined with immunotherapy cures metastatic triple-negative breast cancer.

Incorrect90%

1 AI checked

A 59-year-old woman with Stage 4 breast cancer (6 cm primary tumor and multiple liver metastases) became completely cancer-free in 3 months using high-dose ivermectin (72 mg/day) and fenbendazole (1500 mg/day).

Incorrect93%

4 of 7 AIs agree·ChatGPT: Can’t verify, Perplexity: Can’t verify, Perplexity: Can’t verify

Ivermectin is a proven anticancer treatment in humans.

Incorrect95%

1 AI checked

Fenbendazole is a proven anticancer treatment in humans.

Incorrect95%

1 AI checked

Large doses of ivermectin are safe for cancer patients.

Incorrect95%

1 AI checked

There is strong scientific evidence that ivermectin and fenbendazole can cure advanced cancers in humans.

Incorrect95%

1 AI checked

High-dose ivermectin (72mg/day) is safe

Misleading90%

1 AI checked

These drugs caused the cancer remission described

Can’t verify50%

1 AI checked

Stage 4 breast cancer can achieve complete remission in 3 months with these drugs

Can’t verify65%

1 AI checked

Verified against 9 sources

Detailed Analysis

There is no independent clinical evidence that high‑dose ivermectin and fenbendazole can rapidly cure stage 4 breast cancer, and major cancer organizations explicitly warn against their use as cancer treatments. The described case appears to come from an anecdotal testimonial, not from a verified medical report or trial, so it cannot be confirmed or robustly refuted. Overall, the claim promotes an unproven and potentially dangerous treatment regimen without supporting clinical data.

Why this verdict

There is no independent clinical evidence that high‑dose ivermectin and fenbendazole can rapidly cure stage 4 breast cancer, and major cancer organizations explicitly warn against their use as cancer treatments.
The described case appears to come from an anecdotal testimonial, not from a verified medical report or trial, so it cannot be confirmed or robustly refuted.
Overall, the claim promotes an unproven and potentially dangerous treatment regimen without supporting clinical data.

Claims checked

High-dose ivermectin (72 mg/day) can safely and effectively cure stage 4 breast cancer in humans.

Incorrect90%

This claim may mislead readers without added context.

High-dose fenbendazole (1500 mg/day) can safely and effectively cure stage 4 breast cancer in humans.

Incorrect90%

Fenbendazole is a veterinary antiparasitic drug with some anti-tumor effects shown only in cell and animal models, but there are no clinical trials demonstrating safety or efficacy as a cancer treatment in humans.[1] [4] [6] ASCO and other expert bodies specifically recommend against using fenbendazole for cancer treatment.[7]

This claim may mislead readers without added context.

There are clinical trials showing that ivermectin combined with immunotherapy cures metastatic triple-negative breast cancer.

Incorrect90%

A phase 1/2 study adding ivermectin to immunotherapy for metastatic triple-negative breast cancer showed no clear benefit, with response rates similar to immunotherapy alone and no evidence of cures attributable to ivermectin.[2] No clinical guidelines or trials report ivermectin as curative for this condition.[2] [4] [7]

This claim may mislead readers without added context.

What other AI think

The claim makes multiple assertions that are contradicted by current medical evidence. While some recent observational studies report patient-reported benefits, the major medical organizations explicitly recommend against these treatments for cancer, and the dosages mentioned exceed established safety limits. The claim presents an unverified anecdote as established fact without acknowledging the lack of clinical evidence.

Why this verdict

The claim makes multiple assertions that are contradicted by current medical evidence.
While some recent observational studies report patient-reported benefits, the major medical organizations explicitly recommend against these treatments for cancer, and the dosages mentioned exceed established safety limits.
The claim presents an unverified anecdote as established fact without acknowledging the lack of clinical evidence.

Claims checked

Ivermectin and fenbendazole are effective cancer treatments

Incorrect95%

<cite index="1-2,1-7">There is no robust, peer-reviewed clinical evidence demonstrating that either ivermectin or fenbendazole is safe or effective for treating any human malignancy.</cite> <cite index="4-1,4-3">Ivermectin is not approved to treat any cancer in people or in animals, and no clinical guidelines recommend it as a cancer treatment.</cite>

This claim may mislead readers without added context.

High-dose ivermectin (72mg/day) is safe

Misleading90%

<cite index="1-6">Achieving drug concentrations required to replicate preclinical effects in humans would likely require doses far exceeding established safety limits.</cite> <cite index="18-2">Ivermectin toxicity developed in predominantly male patients >60 years old who ingested higher than recommended doses and developed neurologic symptoms.</cite> The 72mg/day dose is substantially higher than standard therapeutic doses.

This claim may mislead readers without added context.

These drugs caused the cancer remission described

Can’t verify50%

The claim presents a single anecdote without medical documentation, imaging confirmation, or exclusion of other treatments. No causal relationship can be established from an unverified case report. <cite index="1-3,1-4">These agents gained traction as a cancer 'cure' through anecdotal reports and social media campaigns, with viral promotion prompting patients to self-medicate often without their oncology care teams' knowledge.</cite>

The claim makes a strong, time‑sensitive medical assertion that exceeds available evidence. There are no high‑quality clinical trials or verified case reports showing that 72 mg/day ivermectin plus 1500 mg/day fenbendazole reliably produces a complete remission of stage IV breast cancer in three months. Anecdotal reports and small uncontrolled case series exist, and safety concerns (including liver injury) have been documented, so the claim is not proven but also not definitively disprovable from public sources.

Why this verdict

The claim makes a strong, time‑sensitive medical assertion that exceeds available evidence.
There are no high‑quality clinical trials or verified case reports showing that 72 mg/day ivermectin plus 1500 mg/day fenbendazole reliably produces a complete remission of stage IV breast cancer in three months.
Anecdotal reports and small uncontrolled case series exist, and safety concerns (including liver injury) have been documented, so the claim is not proven but also not definitively disprovable from public sources.

Claims checked

Can’t verify70%

I could not find any verified, peer‑reviewed case report or clinical trial documenting this exact patient, dosing regimen, and rapid complete remission. There are anecdotal reports and small observational case series describing self‑administration of fenbendazole and ivermectin, but no rigorous evidence confirming causation or this specific outcome.

Share this result

Try DoubleChecks